Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patients
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
The α-synuclein protein exists in different structural forms primarily as monomers, dimers, and tetramers in different human tissues. In the brain and blood, α-synuclein tetramer to monomer ratios are observed to be altered in sporadic and familial Parkinson’s disease (sPD), and dementia with Lewy bodies (DLB). (Figure presented.)
Details
Original language | English |
---|---|
Pages (from-to) | 1657-1674 |
Number of pages | 18 |
Journal | EMBO molecular medicine |
Volume | 16 |
Issue number | 7 |
Publication status | Published - Jul 2024 |
Peer-reviewed | Yes |
External IDs
PubMedCentral | PMC11250827 |
---|---|
Scopus | 85195313330 |
ORCID | /0000-0002-2387-526X/work/176343351 |
Keywords
Sustainable Development Goals
Keywords
- Aged, Female, Humans, Male, Middle Aged, Parkinson Disease/blood, Protein Aggregates, Protein Multimerization, alpha-Synuclein/metabolism